Skip to main content
NCBI home page
Archives of Disease in Childhood. Fetal and Neonatal Edition logoLink to Archives of Disease in Childhood. Fetal and Neonatal Edition
. 2004 Jul;89(4):F297–F299. doi: 10.1136/adc.2003.027565

Theophylline and gastric emptying in very low birthweight neonates: a randomised controlled trial

A Gounaris, P Kokori, L Varchalama, K Konstandinidi, M Skouroliakou, N Alexiou, C Costalos
PMCID: PMC1721716  PMID: 15210659

Abstract

Background: Theophylline treatment causes side effects such as tachycardia, hyperglycaemia, abdominal distension, and vomiting. The latter two are probably the result of delayed gastric evacuation.

Objective: To study the effect of theophylline on gastric emptying time in preterm infants.

Patients: The subjects were 18 premature neonates with a mean (SD) birth weight of 1302 (240) g and a mean (SD) gestational age of 28.7 (1.9) weeks.

Main outcome measures: In each case, gastric emptying was measured on two occasions: once when the newborns were being treated with theophylline and once when they were not. Half of the cases were randomised to receive theophylline before the initial measurement. The opposite was applied for the rest. Gastric emptying was assessed ultrasonically by measuring the change in antral cross sectional area (ACSA) at regular intervals over 120 minutes.

Results: The mean (SD) ACSA half time in the newborns receiving theophylline was 52 (19) minutes compared with 37 (16) minutes in those not receiving theophylline. This difference is significant (p < 0.05).

Conclusions: Treatment with theophylline seems to delay gastric emptying in very low birthweight neonates, and this must be taken into consideration when this drug is used to treat apnoea of prematurity.

Full Text

The Full Text of this article is available as a PDF (71.1 KB).

Figure 1.

Figure 1

Open in a new tab

 Change in antral cross sectional area (ACSA), as a measure of gastric emptying, in neonates receiving or not receiving theophylline. The mean values of the two measurements are shown (solid horizontal lines).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bucher H. U., Duc G. Does caffeine prevent hypoxaemic episodes in premature infants? A randomized controlled trial. Eur J Pediatr. 1988 Apr;147(3):288–291. doi: 10.1007/BF00442697. [DOI] [PubMed] [Google Scholar]
  2. Foster L. J., Trudeau W. L., Goldman A. L. Bronchodilator effects on gastric acid secretion. JAMA. 1979 Jun 15;241(24):2613–2615. [PubMed] [Google Scholar]
  3. Greenough A., Elias-Jones A., Pool J., Morley C. J., Davis J. A. The therapeutic actions of theophylline in preterm ventilated infants. Early Hum Dev. 1985 Oct;12(1):15–22. doi: 10.1016/0378-3782(85)90132-x. [DOI] [PubMed] [Google Scholar]
  4. Holló I. Letter: Intravenous aminophylline and osteoporosis. Lancet. 1973 Nov 24;2(7839):1203–1203. doi: 10.1016/s0140-6736(73)92964-4. [DOI] [PubMed] [Google Scholar]
  5. Hufnal-Miller C. A., Blackmon L., Baumgart S., Pereira G. R. Enteral theophylline and necrotizing enterocolitis in the low-birthweight infant. Clin Pediatr (Phila) 1993 Nov;32(11):647–653. doi: 10.1177/000992289303201102. [DOI] [PubMed] [Google Scholar]
  6. Jacobs M. H., Senior R. M., Kessler G. Clinical experience with theophylline. Relarionships between dosage, serum concentration, and toxicity. JAMA. 1976 May 3;235(18):1983–1986. doi: 10.1001/jama.235.18.1983. [DOI] [PubMed] [Google Scholar]
  7. Levitt G. A., Mushin A., Bellman S., Harvey D. R. Outcome of preterm infants who suffered neonatal apnoeic attacks. Early Hum Dev. 1988 Mar;16(2-3):235–243. doi: 10.1016/0378-3782(88)90104-1. [DOI] [PubMed] [Google Scholar]
  8. Loughnan P. M., Mc Namara J. M. Paroxysmal supraventricular tachycardia during theophylline therapy in a premature infant. J Pediatr. 1978 Jun;92(6):1016–1018. doi: 10.1016/s0022-3476(78)80390-4. [DOI] [PubMed] [Google Scholar]
  9. Lucey J. F. The xanthine treatment of apnea of prematurity. Pediatrics. 1975 May;55(5):584–586. [PubMed] [Google Scholar]
  10. McKenzie S. A., Baillie E., Godfrey S. Effect of practical timing of dosage on theophylline blood levels in asthmatic children treated with choline theophyllinate. Arch Dis Child. 1978 Feb;53(2):167–168. doi: 10.1136/adc.53.2.167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Newell S. J., Chapman S., Booth I. W. Ultrasonic assessment of gastric emptying in the preterm infant. Arch Dis Child. 1993 Jul;69(1 Spec No):32–36. doi: 10.1136/adc.69.1_spec_no.32. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Peliowski A., Finer N. N. A blinded, randomized, placebo-controlled trial to compare theophylline and doxapram for the treatment of apnea of prematurity. J Pediatr. 1990 Apr;116(4):648–653. doi: 10.1016/s0022-3476(05)81620-8. [DOI] [PubMed] [Google Scholar]
  13. Pfaffman M. A., McFarland S. A. Relationship between theophylline-induced relaxation and excitation-contraction coupling in intestinal smooth muscle. Arch Int Pharmacodyn Ther. 1978 Apr;232(2):180–191. [PubMed] [Google Scholar]
  14. Pryds O., Schneider S. Aminophylline reduces cerebral blood flow in stable, preterm infants without affecting the visual evoked potential. Eur J Pediatr. 1991 Mar;150(5):366–369. doi: 10.1007/BF01955942. [DOI] [PubMed] [Google Scholar]
  15. Riezzo G., Indrio F., Montagna O., Tripaldi C., Laforgia N., Chiloiro M., Mautone A. Gastric electrical activity and gastric emptying in preterm newborns fed standard and hydrolysate formulas. J Pediatr Gastroenterol Nutr. 2001 Sep;33(3):290–295. doi: 10.1097/00005176-200109000-00012. [DOI] [PubMed] [Google Scholar]
  16. Sims M. E., Yau G., Rambhatla S., Cabal L., Wu P. Y. Limitations of theophylline in the treatment of apnea of prematurity. Am J Dis Child. 1985 Jun;139(6):567–570. doi: 10.1001/archpedi.1985.02140080037028. [DOI] [PubMed] [Google Scholar]
  17. Tovar J. A., Eizaguirre I., Albert A., Jimenez J. Peutz-Jeghers syndrome in children: report of two cases and review of the literature. J Pediatr Surg. 1983 Feb;18(1):1–6. doi: 10.1016/s0022-3468(83)80262-0. [DOI] [PubMed] [Google Scholar]
  18. WAXLER S. H., SCHACK J. A. Administration of aminophylline (theophylline ethylenediamine). J Am Med Assoc. 1950 Jun 24;143(8):736–739. doi: 10.1001/jama.1950.02910430028010. [DOI] [PubMed] [Google Scholar]
  19. Warszawski D., Gorodischer R., Kaplanski J. Comparative toxicity of caffeine and aminophylline (theophylline ethylenediamine) in young and adult rats. Biol Neonate. 1978;34(1-2):68–71. doi: 10.1159/000241107. [DOI] [PubMed] [Google Scholar]
  20. Wells H., Lloyd W. Inhibition of the hypocalcemic action of thyrocalcitonin by theophylline and isoproterenol. Endocrinology. 1968 Mar;82(3):468–474. doi: 10.1210/endo-82-3-468. [DOI] [PubMed] [Google Scholar]
  21. Yeh T. F., Pildes R. S. Transplacental aminophylline toxicity in a neonate. Lancet. 1977 Apr 23;1(8017):910–910. doi: 10.1016/s0140-6736(77)91240-5. [DOI] [PubMed] [Google Scholar]
  22. Yeh T. F., Pildes R. S. Transplacental aminophylline toxicity in a neonate. Lancet. 1977 Apr 23;1(8017):910–910. doi: 10.1016/s0140-6736(77)91240-5. [DOI] [PubMed] [Google Scholar]
  23. Zwillich C. W., Sutton F. D., Neff T. A., Cohn W. M., Matthay R. A., Weinberger M. M. Theophylline-induced seizures in adults. Correlation with serum concentrations. Ann Intern Med. 1975 Jun;82(6):784–787. doi: 10.7326/0003-4819-82-6-784. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood Fetal and Neonatal Edition are provided here courtesy of BMJ Publishing Group

RESOURCES